<DOC>
	<DOCNO>NCT01572701</DOCNO>
	<brief_summary>This single arm , open label study 24 high risk prostate cancer patient schedule prostatectomy and/or pelvic lymph node dissection . Patients receive single IV dose 99mTc-MIP-1404 ( study drug ) follow SPECT/CT scan 3-6 hour injection . As standard care , patient undergo prostatectomy and/or pelvic lymph node dissection ( PLND ) within two week study drug dosing . Patients may receive second injection study drug within 24 hour surgery measure activity count tissue sample post-surgery , prior pathology processing . 99mTc-MIP-1404 image data evaluate visible uptake compare histopathology .</brief_summary>
	<brief_title>Pilot Study 99mTc-MIP-1404 SPECT/CT Imaging Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Male age 21 year old . 2 . Ability provide sign informed consent willingness comply protocol requirement . 3 . Past biopsy indicate presence adenocarcinoma prostate gland . 4 . Participant deem highrisk potential pelvic lymph node involvement . The criterion highrisk : Patient PSA value &gt; 10 clinical stage T2 high , Gleason score 8 , 9 10 . Patient PSA value &gt; 20 clinical stage T2 high , Gleason score 5 . Participant schedule undergo standard care prostatectomy and/or pelvic lymph node dissection . 6 . Have ( within previous 2 month ) undergo diagnostic CT MRI image prior surgery . 7 . Have ( within previous 2 month ) undergo bone scan image prior surgery . 8 . Participants must agree use acceptable form birth control throughout study period . Participants must use condoms period seven day injection , engage sexual activity . 1 . Participants participate would significantly delay schedule standard care therapy . 2 . Participants administer radioisotope within 5 physical half live prior study enrollment . 3 . Participants medical condition circumstance , opinion Investigator , would significantly decrease obtain reliable data , achieve study objective complete study .</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>